ArticleJournal of cellular immunology2024

Can Molecular Biomarkers be Utilized to Determine Appropriate Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC)?

Prashanth Ashok Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.